2017-03-08,Intersect ENT Submits New Drug Application To FDA For Office-Based RESOLVE Steroid Releasing Implant For Recurrent Chronic Sinus Disease
2017-02-28,Intersect ENT Reports Fourth Quarter And Full Year 2016 Results
2017-02-24,Intersect ENT's PROPEL® Contour Steroid Releasing Sinus Implant (Photo: Business Wire)
2017-02-21,SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Intersect ENT, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors
2017-02-03,Intersect ENT To Report Fourth Quarter And Year 2016 Financial Results
2017-02-01,Intersect ENT To Present At LEERINK Partners Global Healthcare Conference
2017-01-09,Intersect ENT Reports Preliminary Q4 And Year 2016 Revenue
2016-12-30,Commit To Buy Intersect ENT At $10, Earn 16.3% Annualized Using Options
2016-12-20,Intersect ENT To Present At The 35th Annual J.P. Morgan Healthcare Conference
2016-11-16,Notable Wednesday Option Activity: XENT, FRO, NAT
2016-11-15,Intersect ENT To Present At The Piper Jaffray 28th Annual Healthcare Conference
2016-11-04,Noteworthy Friday Option Activity: XENT, W, DTSI
2016-11-03,Intersect ENT To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum
2016-11-02,Intersect ENT Reports Third Quarter 2016 Results
2016-10-18,Intersect ENT Schedules Third Quarter 2016 Earnings Release And Conference Call For November 2, 2016
2016-10-17,Intersect ENT's Investigational RESOLVE Steroid Releasing Implant (Photo: Business Wire)
2016-09-19,Intersect ENT Announces American Rhinologic Society Endorsement Of The Use Of Drug Eluting Sinus Implants
2016-08-29,Intersect ENT Announces Positive Coverage Decision By CareFirst BlueCross BlueShield To Expand Access To PROPEL Steroid Releasing Implants To More Patients
2016-08-02,Intersect ENT Reports Second Quarter 2016 Results
2016-08-01,Intersect ENT Announces FDA Submission Of NOVA Bioabsorbable Steroid Releasing Implant For Patients With Chronic Sinus Disease
2016-07-19,Intersect ENT Schedules Second Quarter 2016 Earnings Release And Conference Call For August 2, 2016
2016-07-18,Strong On High Volume: Intersect ENT (XENT)
2016-07-18,Intersect ENT Announces Preliminary Q2 Revenue And Business Update
2016-07-11,Intersect ENT Announces Publication Of PROGRESS Study Of Steroid Releasing Implant In Patients With Frontal Sinus Disease
2016-07-07,Notable Thursday Option Activity: XENT, LPCN, JWN
2016-06-02,Intersect ENT To Present At William Blair & Company 36th Annual Growth Stock Conference
2016-06-01,Intersect ENT Announces Completion Of Enrollment In RESOLVE II Clinical Trial Of New In-Office Implant For Recurrent Chronic Sinusitis
2016-05-16,Intersect ENT Announces Positive Clinical Results From Pivotal Study Of Newest Steroid Releasing Sinus Implant
2016-05-06,Intersect ENT is Now Oversold (XENT)
2016-05-05,Intersect ENT Reports First Quarter 2016 Results
2016-04-26,Intersect ENT To Present At Bank Of America Merrill Lynch 2016 Health Care Conference
2016-04-19,Intersect ENT Schedules First Quarter 2016 Earnings Release And Conference Call For May 5, 2016
2016-04-08,Commit To Purchase Intersect ENT At $17.50, Earn 25.5% Annualized Using Options
2016-03-23,Intersect ENT Announces FDA Approval Of Additional Indication For PROPEL® Mini Sinus Implant
2016-02-23,Intersect ENT Reports Fourth Quarter And Year 2015 Results
2016-02-22,David Lehman, General Counsel, Intersect ENT (Photo: Business Wire)
2016-02-12,Intersect ENT To Report Fourth Quarter And Year 2015 Financial Results
2016-02-01,Intersect ENT To Present At LEERINK Partners Global Healthcare Conference
2016-01-29,Intersect ENT Announces NUB Status 1 Designation For PROPEL Sinus Implant In Germany
2016-01-25,Insider Trading Alert - TRUP, XENT And EA Traded By Insiders
2016-01-11,Intersect ENT Reports Preliminary Q4 And Year 2015 Revenue
2015-12-16,Intersect ENT To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-11-17,Intersect ENT Recognized For Gender Diversity By Watermark And UC Davis
2015-11-12,Intersect ENT To Present At Piper Jaffray Conference
2015-11-10,Intersect ENT Announces Data Further Demonstrating Health Economic Value Of PROPEL Steroid Releasing Implants
2015-11-04,Intersect ENT Reports Third Quarter 2015 Results
2015-11-02,Intersect ENT To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum
2015-10-21,Intersect ENT Announces Publication Of Position Statement From AAO-HNS On Use Of Biomaterials
2015-10-20,Intersect ENT To Announce Third Quarter Financial Results
2015-10-02,Trade-Ideas: Intersect ENT (XENT) Is Today's "Dead Cat Bounce" Stock
2015-09-29,Intersect ENT (XENT) Strong On High Relative Volume Today
2015-09-29,Intersect ENT Announces FDA Submission To Seek Expanded Indication Of PROPEL Mini Steroid Releasing Implant To Treat Patients With Frontal Sinus Disease
2015-09-28,Intersect ENT Announces Positive Clinical Results From Three Studies Evaluating Steroid Releasing Implants Placed In The Physician's Office
2015-09-21,Strong On High Volume: Intersect ENT (XENT)
2015-09-09,Intersect ENT is Now Oversold (XENT)
2015-08-25,Ratings Changes Today
2015-08-17,Intersect ENT Announces Positive Preliminary Clinical Results For The PROPEL Mini Steroid Releasing Implant In Patients With Frontal Sinus Disease
2015-08-05,Intersect ENT Reports Second Quarter 2015 Results
2015-07-23,Intersect ENT To Present At The Wedbush PacGrow Life Sciences And Canaccord Genuity Conferences
2015-07-21,Intersect ENT To Announce Second Quarter Financial Results
2015-07-08,Intersect ENT Enrolls First Patient In Pivotal Study To Evaluate The NOVA Sinus Implant
2015-07-02,Intersect ENT To Present At Cantor Fitzgerald's Inaugural Healthcare Conference
2015-06-30,Analysts' Actions -- Abercrombie, Fitbit, Lowe's and More
2015-06-29,Nevro Appoints Lisa Earnhardt To Its Board Of Directors
2015-06-03,Intersect ENT To Present At The William Blair & Company 35th Annual Growth Stock Conference
2015-06-03,Intersect ENT (XEXT) Stock Gains After Upsizing Secondary Offering
2015-06-02,Intersect ENT Announces Upsizing And Pricing Of Public Offering
2015-06-01,Intersect ENT Commences Public Offering
2015-05-20,Intersect ENT Files S-1 Registration Statement For Proposed Public Offering
2015-05-06,Intersect ENT Reports First Quarter 2015 Results
2015-05-04,Intersect ENT Announces Positive Coverage Decision By Health Care Service Corporation
2015-04-22,Intersect ENT To Announce First Quarter Financial Results
2015-04-09,Intersect ENT Appoints Kieran Gallahue And Tony Vernon To Board Of Directors
2015-02-26,Intersect ENT Reports Fourth Quarter And Year 2014 Results
2015-02-23,Intersect ENT To Present At The 27th Annual ROTH Conference
2015-02-10,Intersect ENT To Announce Fourth Quarter And Year 2014 Financial Results
2015-02-02,Intersect ENT Appoints Chas McKhann As Chief Commercial Officer
2015-01-22,Intersect ENT To Present At Leerink Partners Global Healthcare Conference 2015
2015-01-12,Intersect ENT Announces Preliminary 2014 Financial Results
2014-12-29,Intersect ENT Announces Enrollment Of First Patient In Phase III Study Of In-Office Treatment For Recurrent Chronic Sinusitis
2014-12-18,Intersect ENT To Present At J.P. Morgan Healthcare Conference
2014-12-10,Intersect ENT Announces Changes To Board Of Directors
2014-11-11,Intersect ENT To Present At Canaccord Genuity And Piper Jaffray Conferences
2014-11-05,Intersect ENT Reports Third Quarter 2014 Results
2014-10-21,Intersect ENT To Announce Third Quarter Financial Results
2014-10-08,Intersect ENT Announces Publication Of Positive Data From Three Studies Of Company's Drug-Eluting Sinus Implants
2014-10-01,Intersect ENT Added To Russell 2000 Index
2014-09-22,Photo Release -- Intersect ENT Announces Positive Data From Clinical Trial Of New In-Office Implant For Recurrent Chronic Sinusitis
2014-09-17,Intersect ENT Enrolls First Patient In Clinical Study To Expand Access To PROPEL Treatment To Broader Patient Population
2014-09-03,Intersect ENT Reports Second Quarter 2014 Results
2014-08-22,Intersect ENT To Announce Second Quarter Financial Results
2014-08-11,Study Indicates Cost Effectiveness Of Intersect ENT's PROPEL Implant For Chronic Sinusitis
2014-07-29,Intersect ENT Announces Closing Of Its Initial Public Offering
2014-07-24,Intersect ENT (XENT) Stock Pops on First Trading Day After IPO
2014-07-24,Intersect ENT Announces Pricing Of Its Initial Public Offering
,
,
